Teva Pharmaceutical Industries (TEVA) Leases (2018 - 2025)
Historic Leases for Teva Pharmaceutical Industries (TEVA) over the last 11 years, with Q4 2025 value amounting to $345.0 million.
- Teva Pharmaceutical Industries' Leases fell 599.46% to $345.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $345.0 million, marking a year-over-year decrease of 599.46%. This contributed to the annual value of $345.0 million for FY2025, which is 599.46% down from last year.
- According to the latest figures from Q4 2025, Teva Pharmaceutical Industries' Leases is $345.0 million, which was down 599.46% from $342.0 million recorded in Q3 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Leases ranged from a high of $531.0 million in Q2 2021 and a low of $342.0 million during Q3 2025
- Its 5-year average for Leases is $415.5 million, with a median of $412.0 million in 2023.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Leases surged by 58513.51% in 2021 and then tumbled by 1694.92% in 2022.
- Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Leases stood at $495.0 million in 2021, then decreased by 15.35% to $419.0 million in 2022, then fell by 5.25% to $397.0 million in 2023, then dropped by 7.56% to $367.0 million in 2024, then fell by 5.99% to $345.0 million in 2025.
- Its last three reported values are $345.0 million in Q4 2025, $342.0 million for Q3 2025, and $358.0 million during Q2 2025.